Study finds fasting-mimicking diet may reduce biological age and disease risk

Study finds fasting-mimicking diet reduces biological age and disease risk

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Three cycles of FMD found to lower biological age by 2.5 years along with reduced insulin resistance, lower hepatic fat, and improved immune system function.

A new study published in Nature this week suggests that a fasting-mimicking diet (FMD) may be able to reduce biological age and disease risk. Low in protein and carbohydrates, and high in healthy fats, FMD is a diet that mimics the effects of fasting without the need to completely abstain from food. Participants consume around 500-600 calories per day over a five day period – less than half the typical daily intake of 2,000 calories.

The study, which involved two clinical trials and a total of 100 participants, found that people who completed three cycles of FMD, spaced four months apart, had reduced insulin resistance, lower hepatic fat, and improved immune system function. Additionally, participants’ biological age was estimated to be 2.5 years younger on average, based on the 10-biomarker NHANES measure of biological age.

The findings suggest that FMD may be a beneficial intervention for promoting healthy aging, in part due to its ability to reduce inflammation and improve cellular repair mechanisms. The researchers also suggest that FMD may help protect against age-related diseases such as heart disease, cancer, and diabetes, but say that more research is needed to confirm these results and to determine the diet’s long-term effects.

Renowned biogerontologist and cell biologist Dr Valter Longo is the man behind FMD, and whose research earned him a place on TIME Magazine’s list of the 50 most influential people in healthcare in 2018.

“I think the more extreme approaches, such as daily caloric restriction, are too much for most people, which is why I’m really optimistic about the fasting-mimicking diet,” Longo previously told us. “People can do it two or three times a year and then do what they need to do for the rest of the year. We’ve already had hundreds of thousands of people, tens of thousands of doctors, and many clinical trials using it around the world.”

Based on his work, Longo founded longevity nutrition company L-Nutra, which offers a range of food products designed to mimic many of the effects of fasting. The company’s flagship ProLon meal program is essentially a food box filled with five-days’ worth of specially developed powdered soups, bars, liquids, and nutritional supplements.

“It’s a low calorie diet, but it’s also tricking your cells into thinking they aren’t getting any food, so we keep your body in fasting mode during these five days,” L-Nutra CEO Joseph Antoun told us. “So your cells are receiving some of the nutrients but not in an acute high dose, so you’re getting the nutrients but the stress on the cells is still there, which in many ways is even better than water fasting.”

READ MORE: Valter Longo on fasting and longevity

LTUI: 2536

L-Nutra

Longevity level(s):

  • Level 3: Longevity biohacking
    Companies that manufacture ingredients and dietary supplements, or produce equipment such as red light therapy, cryonic chambers, and enhanced exercise equipment to maintain the metabolism and replace cellular function lost with the progression of age.
  • Level 4: Longevity clinical services
    Professionally qualified clinics that offer diagnosis of health and aging biomarkers; clinical guidance on lifestyle, diet and therapeutic interventions to mitigate the progression of age.
  • Level 6: Aging disease prevention therapeutics
    Therapeutic interventions that control aging drivers to prevent aging diseases from occurring, like the current wave of GLP-1 agonists that prevent type 2 diabetes through metabolic interventions that also are proving effective in mitigating cardiovascular and neurological diseases.

Overview

L-Nutra is a nutrition technology company pioneering the discovery, design, and commercialization of plant-based nutrition programs and therapeutics targeting cellular aging and chronic metabolic disease. The company develops fasting-mimicking diet formulations and interventional nutrition therapies designed to activate cellular rejuvenation mechanisms including autophagy and cellular reprogramming. L-Nutra operates across consumer wellness and clinical care divisions, with its flagship product Prolon and medical division L-Nutra Health focused on metabolic health restoration and disease remission. Supported by 47 clinical trials and 137 granted patents, the company aims to redefine nutrition as a primary therapeutic modality for extending healthspan and preventing age-related disease.

Access all data points on DLT:

  • Financial Data
  • Patents
  • Technology
  • Management
  • Advisory Board
  • News
  • Classifications
  • Similar Companies
Expand

Danny Sullivan

Danny has worked in technology communications for more than 20 years, and has been writing about developments the longevity sector since 2019. With a keen interest in the transfer of technology to market, he focuses primarily on the companies working on cutting-edge solutions to aging and age-related diseases.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Longevity investors put evidence to the test

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE